Results 191 to 200 of about 726,956 (307)

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

KERMIT: Performance indicators in electronic patient reported outcome measures: a modified Delphi. [PDF]

J Patient Rep Outcomes
Hatton NL, Baxter M, Lewis S, Hall PS, Spencer K.   +4 more
europepmc   +1 more source

A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity [PDF]

, 2014
Reena Khanna, Guangyong Zou, Geert D’Haens, Brian G. Feagan, William J. Sandborn, Margaret K. Vandervoort, Robert Rolleri, Enoch Bortey, Craig Paterson, William P. Forbes, Barrett G. Levesque   +10 more
openalex   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source

Correction: Patient-reported outcome measures and physical function following head and neck lymphedema - a systematic review. [PDF]

J Cancer Surviv
Gaitatzis K, Thompson B, Blake FT, Koelmeyer L.   +3 more
europepmc   +1 more source

An introduction to patient-reported outcome measures (PROMs) in physiotherapy [PDF]

, 2014
Derek Kyte, Melanie Calvert, Philip J. van der Wees, Ruth ten Hove, Stephanie S. Tolan, Jonathan Hill   +5 more
openalex   +1 more source

The ACCEPTance of automation: refining circulating tumor cells enumeration for improved metastatic colorectal cancer prognosis

Molecular Oncology, EarlyView.
This study highlights the potential of automated enumeration using the ACCEPT software to refine circulating tumor cell (CTC) detection in metastatic colorectal cancer (mCRC). The automated method demonstrates improved accuracy and reduced variability compared to the manual approach.
Michela De Meo, Marco Siringo, Alessandro Vici, Ann Zeuner, Orietta Gandini, Paola Gazzaniga, Chiara Nicolazzo   +6 more
wiley   +1 more source

Interviewing to develop Patient-Reported Outcome (PRO) measures for clinical research: eliciting patients’ experience [PDF]

, 2014
Anne Brédart, Alexia Marrel, Linda Abetz‐Webb, Kathy Lasch, C. Acquadro   +4 more
openalex   +1 more source

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

Molecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak, Bodee Nutho, Worawat Wattanathana, Narumon Phaonakrop, Bunnatut Panasawatwong, Katharina Erlenbach‐Wuensch, Sittiruk Roytrakul, Regine Schneider‐Stock, Pithi Chanvorachote   +8 more
wiley   +1 more source

Patient-Reported Outcome Measures in Clinical Practice for Tooth Wear: A Literature Review. [PDF]

J Clin Med
Argolinha I, Lobo S, Vieira A, Botelho J, Rua J, Mendes JJ, Machado V.   +6 more
europepmc   +1 more source